Actively Recruiting
The Impact of Perineural Injection Therapy for Adhesive Capsulitis.
Led by Universiti Teknologi Mara · Updated on 2025-09-04
24
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if Perineural Injection Therapy (PIT) works to treat adhesive capsulitis (frozen shoulder) in adults. It will also learn about the safety of PIT. The main questions it aims to answer are: Does PIT reduce shoulder pain and improve shoulder range of motion more effectively than conventional therapy alone? What side effects or medical problems do participants experience when receiving PIT? Researchers will compare PIT to conventional therapy to see if PIT works better to treat adhesive capsulitis. Participants will: Receive either: PIT once weekly for 6 weeks plus physiotherapy and oral analgesics (excluding NSAIDs), or Conventional therapy only (physiotherapy and analgesics including NSAIDs) Attend scheduled follow-up visits at Week 6, 1 month, and 3 months after treatment Perform daily home-based shoulder exercises and record their analgesic use and any side effects in a patient diary
CONDITIONS
Official Title
The Impact of Perineural Injection Therapy for Adhesive Capsulitis.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 and above.
- Diagnosed with primary adhesive capsulitis by a specialist.
- Limitation of shoulder range of motion 50% or more compared to the normal side in three or more movement directions.
- Chronic adhesive capsulitis shoulder pain lasting at least 3 months.
- Pain score of at least 4 out of 10 on the Numerical Rating Scale during movement.
- Consent to participate in the study.
You will not qualify if you...
- Received any shoulder injection within the past 6 weeks or surgery for capsular release.
- Diagnosed with other shoulder problems such as neurologic deficits, tumor, rotator cuff injury, or fracture.
- History of allergy to dextrose solution.
- Currently taking steroids, immunosuppressants, psychotropic medication, or other medications that may affect study outcomes.
- Have hemorrhagic disease, take anticoagulant drugs, or have severe diabetes with increased infection risk (HbA1c >8%).
- Cannot understand Malay or English.
- Unable to follow a 3-step command.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Al-Sultan Abdullah, UiTM Puncak Alam
Kuala Selangor, Selangor, Malaysia, 42300
Actively Recruiting
Research Team
N
Noor Hafizah Samsudin Bahari, MD(UKM)
CONTACT
D
Dr Anie Farhana Ngimron, MBBChBAO(Ireland)MRehabMed(UM)
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here